Rationale: Idiopathic pulmonary fibrosis (IPF) is an insidious and fatal interstitial lung disease associated with declining pulmonary function. Accelerated aging, loss of epithelial progenitor cell function and/or numbers, and cellular senescence are implicated in the pathogenies of IPF. Objectives: We sought to investigate the role of alveolar type 2 (AT2) cellular senescence in initiation and/or progression of pulmonary fibrosis and therapeutic potential of targeting senescence-related pathways and senescent cells. Methods: Epithelial cells of 9 control donor proximal and distal lung tissues and 11 IPF fibrotic lung tissues were profiled by single-cell RNA sequencing to assesses the contribution of epithelial cells to the senescent cell fraction for IPF. A novel mouse model of conditional AT2 cell senescence was generated to study the role of cellular senescence in pulmonary fibrosis.Measurements and Main Results: We show that AT2 cells isolated from IPF lung tissue exhibit characteristic transcriptomic features of cellular senescence. We used conditional loss of Sin3a in adult mouse AT2 cells to initiate a program of p53-dependent cellular senescence, AT2 cell depletion, and spontaneous, progressive pulmonary fibrosis. We establish that senescence rather than loss of AT2 cells promotes progressive fibrosis and show that either genetic or pharmacologic interventions targeting p53 activation or senescence block fibrogenesis.Conclusions: Senescence of AT2 cells is sufficient to drive progressive pulmonary fibrosis. Early attenuation of senescence-related pathways and elimination of senescent cells are promising therapeutic approaches to prevent pulmonary fibrosis.
Rationale: Idiopathic pulmonary fibrosis (IPF) is an insidious and fatal interstitial lung disease associated with declining pulmonary function. Accelerated aging, loss of epithelial progenitor cell function and/or numbers, and cellular senescence are implicated in the pathogenies of IPF. Objectives: We sought to investigate the role of alveolar type 2 (AT2) cellular senescence in initiation and/or progression of pulmonary fibrosis and therapeutic potential of targeting senescence-related pathways and senescent cells. Methods: Epithelial cells of 9 control donor proximal and distal lung tissues and 11 IPF fibrotic lung tissues were profiled by single-cell RNA sequencing to assesses the contribution of epithelial cells to the senescent cell fraction for IPF. A novel mouse model of conditional AT2 cell senescence was generated to study the role of cellular senescence in pulmonary fibrosis.Measurements and Main Results: We show that AT2 cells isolated from IPF lung tissue exhibit characteristic transcriptomic features of cellular senescence. We used conditional loss of Sin3a in adult mouse AT2 cells to initiate a program of p53-dependent cellular senescence, AT2 cell depletion, and spontaneous, progressive pulmonary fibrosis. We establish that senescence rather than loss of AT2 cells promotes progressive fibrosis and show that either genetic or pharmacologic interventions targeting p53 activation or senescence block fibrogenesis.Conclusions: Senescence of AT2 cells is sufficient to drive progressive pulmonary fibrosis. Early attenuation of senescence-related pathways and elimination of senescent cells are promising therapeutic approaches to prevent pulmonary fibrosis.
Entities:
Keywords:
alveolar type 2 cells; cellular senescence; pulmonary fibrosis
Authors: Silvina V Sonzogni; María Florencia Ogara; Laura M Belluscio; Daniela S Castillo; María E Scassa; Eduardo T Cánepa Journal: Biochim Biophys Acta Date: 2014-03-22
Authors: Mareike Lehmann; Martina Korfei; Kathrin Mutze; Stephan Klee; Wioletta Skronska-Wasek; Hani N Alsafadi; Chiharu Ota; Rita Costa; Herbert B Schiller; Michael Lindner; Darcy E Wagner; Andreas Günther; Melanie Königshoff Journal: Eur Respir J Date: 2017-08-03 Impact factor: 16.671
Authors: Marissa J Schafer; Thomas A White; Koji Iijima; Andrew J Haak; Giovanni Ligresti; Elizabeth J Atkinson; Ann L Oberg; Jodie Birch; Hanna Salmonowicz; Yi Zhu; Daniel L Mazula; Robert W Brooks; Heike Fuhrmann-Stroissnigg; Tamar Pirtskhalava; Y S Prakash; Tamara Tchkonia; Paul D Robbins; Marie Christine Aubry; João F Passos; James L Kirkland; Daniel J Tschumperlin; Hirohito Kita; Nathan K LeBrasseur Journal: Nat Commun Date: 2017-02-23 Impact factor: 14.919
Authors: Arun C Habermann; Austin J Gutierrez; Linh T Bui; Stephanie L Yahn; Nichelle I Winters; Carla L Calvi; Lance Peter; Mei-I Chung; Chase J Taylor; Christopher Jetter; Latha Raju; Jamie Roberson; Guixiao Ding; Lori Wood; Jennifer M S Sucre; Bradley W Richmond; Ana P Serezani; Wyatt J McDonnell; Simon B Mallal; Matthew J Bacchetta; James E Loyd; Ciara M Shaver; Lorraine B Ware; Ross Bremner; Rajat Walia; Timothy S Blackwell; Nicholas E Banovich; Jonathan A Kropski Journal: Sci Adv Date: 2020-07-08 Impact factor: 14.136
Authors: Vincent C Auyeung; Michael S Downey; Maike Thamsen; Talia A Wenger; Bradley J Backes; Dean Sheppard; Feroz R Papa Journal: Am J Physiol Lung Cell Mol Physiol Date: 2022-02-16 Impact factor: 5.464
Authors: Anna J Podolanczuk; Alyson W Wong; Shigeki Saito; Joseph A Lasky; Christopher J Ryerson; Oliver Eickelberg Journal: Am J Respir Crit Care Med Date: 2021-06-01 Impact factor: 21.405
Authors: Aernoud A van Batenburg; Karin M Kazemier; Matthijs F M van Oosterhout; Joanne J van der Vis; Jan C Grutters; Roel Goldschmeding; Coline H M van Moorsel Journal: ERJ Open Res Date: 2021-05-31
Authors: Amitava Mukherjee; Michael W Epperly; Renee Fisher; Wen Hou; Donna Shields; Hong Wang; Joel S Greenberger; Luis A Ortiz Journal: In Vivo Date: 2021 Nov-Dec Impact factor: 2.155